Lista de obras - Francesco Dazzi - Dominio Público Uruguay

A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report.

artículo científico publicado en 1995

Acute myeloid leukaemia niche regulates response to L-asparaginase

scientific article published on 01 May 2019

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

artículo científico publicado en 2013

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

artículo científico publicado en 2004

Adoptive Immunotherapy Following Allogeneic Bone Marrow Transplantation ⬇️

artículo científico publicado el 1 de enero de 1998

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

scientific article published on 01 May 1998

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

artículo científico publicado en 2017

Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity

artículo científico publicado en 2019

Are the imaging findings used to assess the portal triad reliable to perform living-donor liver transplant?

artículo científico publicado en 2013

Basic research and clinical applications of non-hematopoietic stem cells, 4–5 April 2008, Tübingen, Germany

article

Bi-directional cell-pericellular matrix interactions direct stem cell fate

artículo científico publicado en 2018

Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen.

artículo científico publicado en 1994

Bone Marrow Transplantation 1957-2019.

artículo científico publicado en 2019

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

artículo científico publicado en 2004

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide

artículo científico publicado en 2002

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery

artículo científico publicado en 2017

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis

artículo científico publicado en 2010

CD25-negative hairy cell leukaemia: Intracytoplasmic detection of Tac antigen and interferon-induced surface expression

artículo científico publicado en 1995

Cancer makes new friends with old tricks ⬇️

artículo científico publicado el 15 de agosto de 2013

Cell therapy for autoimmune diseases

artículo científico publicado en 2007

Challenges for mesenchymal stromal cell therapies

scientific article published on 01 February 2019

Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

scientific article published on 23 March 2006

Chronic GVHD as an autoimmune disease

artículo científico publicado en 2008

Classification and biology of tumour associated stromal cells

artículo científico

Clinical perspectives of mesenchymal stem cells

artículo científico publicado en 2012

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells

artículo científico publicado en 2013

Comparison of human isogeneic Wharton's jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation

article

Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis

artículo científico publicado en 2016

Correction of severe anaemia using immuno-regulated gene therapy is achieved by restoring the early erythroblast compartment

artículo científico publicado en 2006

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

artículo científico publicado en 2001

Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML.

artículo científico publicado en 2009

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

artículo científico publicado en 2002

Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation

artículo científico publicado en 2008

Donor Lymphocyte Infusions for Patients who Relapse After Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia ⬇️

artículo científico publicado el 1 de enero de 2003

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

artículo científico publicado en 2002

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

artículo científico publicado en 1999

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

artículo científico publicado en 2012

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

artículo científico publicado en 2011

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

scientific article published on 01 March 2001

Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation

artículo científico publicado en 2010

Effects of maternal obesity on Wharton's Jelly mesenchymal stromal cells

artículo científico publicado en 2017

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy.

artículo científico publicado en 2010

Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?

artículo científico publicado en 2013

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT.

artículo científico publicado en 2013

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

artículo científico publicado en 2008

Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and Alloantigens

artículo científico publicado en 1995

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation

artículo científico publicado en 2005

Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides

artículo científico publicado en 2009

Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies.

artículo científico publicado en 2018

High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII.

artículo científico publicado en 1996

Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras

scientific article published on 19 July 2019

Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo

artículo científico publicado en 2016

Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation

artículo científico publicado en 2002

Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.

artículo científico publicado en 2001

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

artículo científico publicado en 2018

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

artículo científico publicado en 2007

Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

scientific article published on 11 January 2007

Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo

artículo científico publicado en 2010

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

artículo científico publicado en 2015

Living donor right liver lobe transplantation with or without inclusion of the middle hepatic vein: analysis of complications.

artículo científico publicado en 2011

Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

artículo científico publicado en 2008

Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment

artículo científico publicado en 2007

MSCs: science and trials

article published in 2013

Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT).

artículo científico publicado en 2005

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

scientific article published on 20 July 2018

Marked but Transitory Elevation of Hepatic Transaminases after Subcutaneous Calcium Heparin Administration

artículo científico publicado en 1994

Maternal obesity alters characteristics of Wharton's Jelly mesenchymal stromal cells

Mesenchymal stem cell therapy for degenerative inflammatory disorders

artículo científico publicado en 2008

Mesenchymal stem cells and autoimmune diseases

artículo científico publicado en 2011

Mesenchymal stem cells and innate tolerance: biology and clinical applications

artículo científico publicado en 2010

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

artículo científico publicado en 2008

Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

artículo científico publicado en 2008

Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells

artículo científico publicado en 2008

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

artículo científico publicado en 2007

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

artículo científico publicado en 2006

Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease

artículo científico publicado en 2007

Mesenchymal stem cells: the fibroblasts' new clothes?

artículo científico publicado en 2008

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

artículo científico publicado en 2012

Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival

artículo científico publicado en 2019

Mesenchymal stromal cells: a key player in 'innate tolerance'?

artículo científico publicado en 2012

Mesenchymal-myeloid interaction in the regulation of immunity

artículo científico publicado en 2018

Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate

scientific article published on 18 March 2011

Minor H antigens: genes and peptides.

artículo científico publicado en 2001

Minor antigen solves major problem

artículo científico publicado en 2001

Minor histocompatibility antigens and stem cell transplantation.

artículo científico publicado en 2004

Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro.

artículo científico publicado en 2017

Multiparametric Analysis of Circulating Exosomes and Other Small Extracellular Vesicles by Advanced Imaging Flow Cytometry

Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans

artículo científico publicado en 2003

Myasthenic syndrome and oligoclonal lymphocytosis: evolution into chronic lymphocytic leukemia

scientific article published on 01 January 1998

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.

artículo científico publicado en 2009

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

artículo científico publicado en 2019

Potential of mesenchymal stem cell therapy

artículo científico publicado en 2007

Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies

artículo científico publicado en 2017

Prevalence of anti‐FVIII antibodies in severe haemophilia A patients with inversion of intron 22 ⬇️

artículo científico publicado el 1 de junio de 1997

Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29–30 September 2006, Tübingen, Germany

article

Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.

artículo científico publicado en 2013

Rapid and Efficient Stable Gene Transfer to Mesenchymal Stromal Cells Using a Modified Foamy Virus Vector

artículo científico publicado en 2016

Regulatory T cell therapy for the induction of clinical organ transplantation tolerance

artículo científico publicado en 2011

Regulatory T cells in stem cell transplantation: main characters or walk-on actors?

artículo científico

Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer

artículo científico publicado en 2018

Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy

artículo científico publicado en 2007

Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden

scientific article published in 2023

Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia: an attempt to define patients who may not require further therapy

artículo científico publicado en 2006

Strontium can increase some osteoblasts without increasing hematopoietic stem cells

artículo científico publicado en 2007

T-cell receptor repertoire usage after allografting differs between CD4+CD25+ regulatory T cells and their CD4+CD25 counterpart

scientific article published on 01 February 2007

TCRzetadim lymphocytes define populations of circulating effector cells that migrate to inflamed tissues

artículo científico publicado en 2007

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

article

The UKRMP Immunomodulation hub.

artículo científico publicado en 2015

The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

artículo científico publicado en 2007

The diagnostic classification of eating disorders: current situation, possible alternatives and future perspectives

artículo científico publicado en 2013

The failure of female cells to present in vitro the male H-Y antigen for secondary cytotoxic T-cell responses

artículo científico publicado en 1985

The highway code of T cell trafficking.

artículo científico publicado en 2008

The immunomodulatory properties of mesenchymal stem cells

artículo científico publicado en 2011

The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function

artículo científico publicado en 2008

The immunosuppressive properties of mesenchymal stem cells

artículo científico publicado en 2009

The role of mesenchymal stem cells in haemopoiesis

artículo científico publicado en 2005

The therapeutic activity of low-dose irradiation on experimental arthritis depends on the induction of endogenous regulatory T cell activity

article by L. Weng et al published 24 May 2010 in Annals of the Rheumatic Diseases

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

scientific article published on 01 November 2002

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1+subpopulation

artículo científico publicado en 2014

Lista de obras de Francesco Dazzi

A role for platelet-derived growth factor in drug-induced chronic ergotism? A case report.

Acute myeloid leukaemia niche regulates response to L-asparaginase

Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

Adoptive Immunotherapy Following Allogeneic Bone Marrow Transplantation ⬇️

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation.

Apoptotic mesenchymal stromal cells induce prostaglandin E2 in monocytes: implications for the monitoring of mesenchymal stromal cell activity

Are the imaging findings used to assess the portal triad reliable to perform living-donor liver transplant?

Basic research and clinical applications of non-hematopoietic stem cells, 4–5 April 2008, Tübingen, Germany

Bi-directional cell-pericellular matrix interactions direct stem cell fate

Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen.

Bone Marrow Transplantation 1957-2019.

Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells

Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide

Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery

Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis

CD25-negative hairy cell leukaemia: Intracytoplasmic detection of Tac antigen and interferon-induced surface expression

Cancer makes new friends with old tricks ⬇️

Cell therapy for autoimmune diseases

Challenges for mesenchymal stromal cell therapies

Characterization and Clinical Application of Human CD34+Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony-Stimulating Factor

Chronic GVHD as an autoimmune disease

Classification and biology of tumour associated stromal cells

Clinical perspectives of mesenchymal stem cells

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells

Comparison of human isogeneic Wharton's jelly MSCs and iPSC-derived MSCs reveals differentiation-dependent metabolic responses to IFNG stimulation

Complement C3 Exacerbates Imiquimod-Induced Skin Inflammation and Psoriasiform Dermatitis

Correction of severe anaemia using immuno-regulated gene therapy is achieved by restoring the early erythroblast compartment

Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis

Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML.

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation

Donor Lymphocyte Infusions for Patients who Relapse After Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukaemia ⬇️

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Effects of MSC co-injection on the reconstitution of aplastic anemia patient following hematopoietic stem cell transplantation

Effects of maternal obesity on Wharton's Jelly mesenchymal stromal cells

Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy.

Enhanced and aberrant T cell trafficking following total body irradiation: a gateway to graft-versus-host disease?

Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCT.

European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor.

Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and Alloantigens

Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation

HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation

Haemopoietic stem cell transplantation induces tolerance to donor antigens but not to foreign FVIII peptides

Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies.

High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII.

Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras

Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo

Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation

Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions.

Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP.

Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005

Increased frequencies of CD4+CD25high Tregs correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo

International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

Living donor right liver lobe transplantation with or without inclusion of the middle hepatic vein: analysis of complications.

Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease

Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment

MSCs: science and trials

Management of chronic myeloid leukaemia in relapse following donor lymphocyte infusion induced remission: a retrospective study of the Clinical Trials Committee of the British Society of Blood & Marrow Transplantation (BSBMT).

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

Marked but Transitory Elevation of Hepatic Transaminases after Subcutaneous Calcium Heparin Administration

Maternal obesity alters characteristics of Wharton's Jelly mesenchymal stromal cells

Mesenchymal stem cell therapy for degenerative inflammatory disorders

Mesenchymal stem cells and autoimmune diseases

Mesenchymal stem cells and innate tolerance: biology and clinical applications

Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses

Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells

Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease

Mesenchymal stem cells: the fibroblasts' new clothes?

Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?